Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 265 to 271 of 271 entries
Sorted by: Best Match Show Resources per page
SWOG S1820: Altering Intake, Managing Symptoms for bowel dysfunction in survivors of Rectal Cancer (The AIMS-RC intervention trial).

Contemporary clinical trials communications

Sun V, Crane TE, Arnold KB, Guthrie K, Freylersythe S, Braun-Inglis C, Jones L, Cohen SA, Al-Kasspooles M, Krouse RS, Thomson CA.
PMID: 33997460
Contemp Clin Trials Commun. 2021 Apr 08;22:100768. doi: 10.1016/j.conctc.2021.100768. eCollection 2021 Jun.

OBJECTIVE: To describe the study protocol of SWOG S1820, a trial of the Altering Intake, Managing Symptoms intervention for bowel dysfunction in survivors of Rectal Cancer (AIMS-RC).DESIGN: SWOG S1820 is a multi-site, randomized trial of 94 post-treatment survivors of...

Cite
Sun V, Crane TE, Arnold KB, et al. SWOG S1820: Altering Intake, Managing Symptoms for bowel dysfunction in survivors of Rectal Cancer (The AIMS-RC intervention trial). Contemp Clin Trials Commun. 2021;22:100768doi: 10.1016/j.conctc.2021.100768.
Sun, V., Crane, T. E., Arnold, K. B., Guthrie, K., Freylersythe, S., Braun-Inglis, C., Jones, L., Cohen, S. A., Al-Kasspooles, M., Krouse, R. S., & Thomson, C. A. (2021). SWOG S1820: Altering Intake, Managing Symptoms for bowel dysfunction in survivors of Rectal Cancer (The AIMS-RC intervention trial). Contemporary clinical trials communications, 22100768. https://doi.org/10.1016/j.conctc.2021.100768
Sun, Virginia, et al. "SWOG S1820: Altering Intake, Managing Symptoms for bowel dysfunction in survivors of Rectal Cancer (The AIMS-RC intervention trial)." Contemporary clinical trials communications vol. 22 (2021): 100768. doi: https://doi.org/10.1016/j.conctc.2021.100768
Sun V, Crane TE, Arnold KB, Guthrie K, Freylersythe S, Braun-Inglis C, Jones L, Cohen SA, Al-Kasspooles M, Krouse RS, Thomson CA. SWOG S1820: Altering Intake, Managing Symptoms for bowel dysfunction in survivors of Rectal Cancer (The AIMS-RC intervention trial). Contemp Clin Trials Commun. 2021 Apr 08;22:100768. doi: 10.1016/j.conctc.2021.100768. eCollection 2021 Jun. PMID: 33997460; PMCID: PMC8105629.
Copy Download .nbib Format: NLM
Help! I Need a Remote Guide in My Mixed Reality Collaborative Environment.

Frontiers in robotics and AI

Le Chénéchal M, Duval T, Gouranton V, Royan J, Arnaldi B.
PMID: 33501121
Front Robot AI. 2019 Nov 15;6:106. doi: 10.3389/frobt.2019.00106. eCollection 2019.

The help of a remote expert in performing a maintenance task can be useful in many situations, and can save time as well as money. In this context, augmented reality (AR) technologies can improve remote guidance thanks to the...

Cite
Le Chénéchal M, Duval T, Gouranton V, et al. Help! I Need a Remote Guide in My Mixed Reality Collaborative Environment. Front Robot AI. 2019;6:106doi: 10.3389/frobt.2019.00106.
Le Chénéchal, M., Duval, T., Gouranton, V., Royan, J., & Arnaldi, B. (2019). Help! I Need a Remote Guide in My Mixed Reality Collaborative Environment. Frontiers in robotics and AI, 6106. https://doi.org/10.3389/frobt.2019.00106
Le Chénéchal, Morgan, et al. "Help! I Need a Remote Guide in My Mixed Reality Collaborative Environment." Frontiers in robotics and AI vol. 6 (2019): 106. doi: https://doi.org/10.3389/frobt.2019.00106
Le Chénéchal M, Duval T, Gouranton V, Royan J, Arnaldi B. Help! I Need a Remote Guide in My Mixed Reality Collaborative Environment. Front Robot AI. 2019 Nov 15;6:106. doi: 10.3389/frobt.2019.00106. eCollection 2019. PMID: 33501121; PMCID: PMC7805679.
Copy Download .nbib Format: NLM
A Novel Role of BIRC3 in Stemness Reprogramming of Glioblastoma.

International journal of molecular sciences

Wu Q, Berglund AE, MacAulay RJ, Etame AB.
PMID: 35008722
Int J Mol Sci. 2021 Dec 28;23(1). doi: 10.3390/ijms23010297.

Stemness reprogramming remains a largely unaddressed principal cause of lethality in glioblastoma (GBM). It is therefore of utmost importance to identify and target mechanisms that are essential for GBM stemness and self-renewal. Previously, we implicated BIRC3 as an essential...

Cite
Wu Q, Berglund AE, MacAulay RJ, et al. A Novel Role of BIRC3 in Stemness Reprogramming of Glioblastoma. Int J Mol Sci. 2021;23(1)doi: 10.3390/ijms23010297.
Wu, Q., Berglund, A. E., MacAulay, R. J., & Etame, A. B. (2021). A Novel Role of BIRC3 in Stemness Reprogramming of Glioblastoma. International journal of molecular sciences, 23(1), . https://doi.org/10.3390/ijms23010297
Wu, Qiong, et al. "A Novel Role of BIRC3 in Stemness Reprogramming of Glioblastoma." International journal of molecular sciences vol. 23,1 (2021). doi: https://doi.org/10.3390/ijms23010297
Wu Q, Berglund AE, MacAulay RJ, Etame AB. A Novel Role of BIRC3 in Stemness Reprogramming of Glioblastoma. Int J Mol Sci. 2021 Dec 28;23(1). doi: 10.3390/ijms23010297. PMID: 35008722; PMCID: PMC8745052.
Copy Download .nbib Format: NLM
The presentation of brain metastases in melanoma, non-small cell lung cancer, and breast cancer and potential implications for screening brain MRIs.

Breast cancer research and treatment

Mills MN, Potluri TK, Kawahara Y, Fahey M, Figura NB, Soyano AE, Washington IR, Diaz R, Oliver DE, Yu HM, Etame AB, Vogelbaum MA, Czerniecki BJ, Arrington JA, Sahebjam S, Forsyth PA, Soliman HH, Han HS, Ahmed KA.
PMID: 34669082
Breast Cancer Res Treat. 2022 Jan;191(1):209-217. doi: 10.1007/s10549-021-06420-3. Epub 2021 Oct 20.

PURPOSE: This study assessed the presentation and institutional outcomes treating brain metastases (BM) of breast cancer (BC), non-small cell lung cancer (NSCLC), and melanoma origin.METHODS: Patients with brain metastases treated between 2014 and 2019 with primary melanoma, NSCLC, and...

Cite
Mills MN, Potluri TK, Kawahara Y, et al. The presentation of brain metastases in melanoma, non-small cell lung cancer, and breast cancer and potential implications for screening brain MRIs. Breast Cancer Res Treat. 2021;191(1):209-217doi: 10.1007/s10549-021-06420-3.
Mills, M. N., Potluri, T. K., Kawahara, Y., Fahey, M., Figura, N. B., Soyano, A. E., Washington, I. R., Diaz, R., Oliver, D. E., Yu, H. M., Etame, A. B., Vogelbaum, M. A., Czerniecki, B. J., Arrington, J. A., Sahebjam, S., Forsyth, P. A., Soliman, H. H., Han, H. S., & Ahmed, K. A. (2022). The presentation of brain metastases in melanoma, non-small cell lung cancer, and breast cancer and potential implications for screening brain MRIs. Breast cancer research and treatment, 191(1), 209-217. https://doi.org/10.1007/s10549-021-06420-3
Mills, Matthew N, et al. "The presentation of brain metastases in melanoma, non-small cell lung cancer, and breast cancer and potential implications for screening brain MRIs." Breast cancer research and treatment vol. 191,1 (2022): 209-217. doi: https://doi.org/10.1007/s10549-021-06420-3
Mills MN, Potluri TK, Kawahara Y, Fahey M, Figura NB, Soyano AE, Washington IR, Diaz R, Oliver DE, Yu HM, Etame AB, Vogelbaum MA, Czerniecki BJ, Arrington JA, Sahebjam S, Forsyth PA, Soliman HH, Han HS, Ahmed KA. The presentation of brain metastases in melanoma, non-small cell lung cancer, and breast cancer and potential implications for screening brain MRIs. Breast Cancer Res Treat. 2022 Jan;191(1):209-217. doi: 10.1007/s10549-021-06420-3. Epub 2021 Oct 20. PMID: 34669082.
Copy Download .nbib Format: NLM
Evaluation of a city-wide school-located influenza vaccination program in Oakland, California with respect to race and ethnicity: A matched cohort study.

Vaccine

Nguyen AT, Arnold BF, Kennedy CJ, Mishra K, Pokpongkiat NN, Seth A, Djajadi S, Holbrook K, Pan E, Kirley PD, Libby T, Hubbard AE, Reingold A, Colford JM, Benjamin-Chung J.
PMID: 34872797
Vaccine. 2022 Jan 21;40(2):266-274. doi: 10.1016/j.vaccine.2021.11.073. Epub 2021 Dec 03.

BACKGROUND: Increasing influenza vaccination coverage in school-aged children may substantially reduce community transmission. School-located influenza vaccinations (SLIV) aim to promote vaccinations by increasing accessibility, which may be especially beneficial to race/ethnicity groups that face high barriers to preventative care....

Cite
Nguyen AT, Arnold BF, Kennedy CJ, et al. Evaluation of a city-wide school-located influenza vaccination program in Oakland, California with respect to race and ethnicity: A matched cohort study. Vaccine. 2021;40(2):266-274doi: 10.1016/j.vaccine.2021.11.073.
Nguyen, A. T., Arnold, B. F., Kennedy, C. J., Mishra, K., Pokpongkiat, N. N., Seth, A., Djajadi, S., Holbrook, K., Pan, E., Kirley, P. D., Libby, T., Hubbard, A. E., Reingold, A., Colford, J. M., & Benjamin-Chung, J. (2022). Evaluation of a city-wide school-located influenza vaccination program in Oakland, California with respect to race and ethnicity: A matched cohort study. Vaccine, 40(2), 266-274. https://doi.org/10.1016/j.vaccine.2021.11.073
Nguyen, Anna T, et al. "Evaluation of a city-wide school-located influenza vaccination program in Oakland, California with respect to race and ethnicity: A matched cohort study." Vaccine vol. 40,2 (2022): 266-274. doi: https://doi.org/10.1016/j.vaccine.2021.11.073
Nguyen AT, Arnold BF, Kennedy CJ, Mishra K, Pokpongkiat NN, Seth A, Djajadi S, Holbrook K, Pan E, Kirley PD, Libby T, Hubbard AE, Reingold A, Colford JM, Benjamin-Chung J. Evaluation of a city-wide school-located influenza vaccination program in Oakland, California with respect to race and ethnicity: A matched cohort study. Vaccine. 2022 Jan 21;40(2):266-274. doi: 10.1016/j.vaccine.2021.11.073. Epub 2021 Dec 03. PMID: 34872797.
Copy Download .nbib Format: NLM
Interfacial Engineering to Tailor the Properties of Multifunctional Ultralight Weight hBN-Polymer Composite Aerogels.

ACS applied materials & interfaces

Ozden S, Dutta NS, Randazzo K, Tsafack T, Arnold CB, Priestley RD.
PMID: 33689272
ACS Appl Mater Interfaces. 2021 Mar 24;13(11):13620-13628. doi: 10.1021/acsami.0c16866. Epub 2021 Mar 09.

A common feature of aerogels is that they are brittle and suffer from poor mechanical properties. The development of high-performance, lightweight, and mechanically robust polymer composite aerogels may find use in a broad range of applications such as packaging,...

Cite
Ozden S, Dutta NS, Randazzo K, et al. Interfacial Engineering to Tailor the Properties of Multifunctional Ultralight Weight hBN-Polymer Composite Aerogels. ACS Appl Mater Interfaces. 2021;13(11):13620-13628doi: 10.1021/acsami.0c16866.
Ozden, S., Dutta, N. S., Randazzo, K., Tsafack, T., Arnold, C. B., & Priestley, R. D. (2021). Interfacial Engineering to Tailor the Properties of Multifunctional Ultralight Weight hBN-Polymer Composite Aerogels. ACS applied materials & interfaces, 13(11), 13620-13628. https://doi.org/10.1021/acsami.0c16866
Ozden, Sehmus, et al. "Interfacial Engineering to Tailor the Properties of Multifunctional Ultralight Weight hBN-Polymer Composite Aerogels." ACS applied materials & interfaces vol. 13,11 (2021): 13620-13628. doi: https://doi.org/10.1021/acsami.0c16866
Ozden S, Dutta NS, Randazzo K, Tsafack T, Arnold CB, Priestley RD. Interfacial Engineering to Tailor the Properties of Multifunctional Ultralight Weight hBN-Polymer Composite Aerogels. ACS Appl Mater Interfaces. 2021 Mar 24;13(11):13620-13628. doi: 10.1021/acsami.0c16866. Epub 2021 Mar 09. PMID: 33689272.
Copy Download .nbib Format: NLM
Water, sanitation, and hygiene for control of trachoma in Ethiopia (WUHA): a two-arm, parallel-group, cluster-randomised trial.

The Lancet. Global health

Aragie S, Wittberg DM, Tadesse W, Dagnew A, Hailu D, Chernet A, Melo JS, Aiemjoy K, Haile M, Zeru T, Tadesse Z, Gwyn S, Martin DL, Arnold BF, Freeman MC, Nash SD, Callahan EK, Porco TC, Lietman TM, Keenan JD.
PMID: 34919861
Lancet Glob Health. 2022 Jan;10(1):e87-e95. doi: 10.1016/S2214-109X(21)00409-5.

BACKGROUND: WHO promotes the SAFE strategy for the elimination of trachoma as a public health programme, which promotes surgery for trichiasis (ie, the S component), antibiotics to clear the ocular strains of chlamydia that cause trachoma (the A component),...

Cite
Aragie S, Wittberg DM, Tadesse W, et al. Water, sanitation, and hygiene for control of trachoma in Ethiopia (WUHA): a two-arm, parallel-group, cluster-randomised trial. Lancet Glob Health. 2022;10(1):e87-e95doi: 10.1016/S2214-109X(21)00409-5.
Aragie, S., Wittberg, D. M., Tadesse, W., Dagnew, A., Hailu, D., Chernet, A., Melo, J. S., Aiemjoy, K., Haile, M., Zeru, T., Tadesse, Z., Gwyn, S., Martin, D. L., Arnold, B. F., Freeman, M. C., Nash, S. D., Callahan, E. K., Porco, T. C., Lietman, T. M., & Keenan, J. D. (2022). Water, sanitation, and hygiene for control of trachoma in Ethiopia (WUHA): a two-arm, parallel-group, cluster-randomised trial. The Lancet. Global health, 10(1), e87-e95. https://doi.org/10.1016/S2214-109X(21)00409-5
Aragie, Solomon, et al. "Water, sanitation, and hygiene for control of trachoma in Ethiopia (WUHA): a two-arm, parallel-group, cluster-randomised trial." The Lancet. Global health vol. 10,1 (2022): e87-e95. doi: https://doi.org/10.1016/S2214-109X(21)00409-5
Aragie S, Wittberg DM, Tadesse W, Dagnew A, Hailu D, Chernet A, Melo JS, Aiemjoy K, Haile M, Zeru T, Tadesse Z, Gwyn S, Martin DL, Arnold BF, Freeman MC, Nash SD, Callahan EK, Porco TC, Lietman TM, Keenan JD. Water, sanitation, and hygiene for control of trachoma in Ethiopia (WUHA): a two-arm, parallel-group, cluster-randomised trial. Lancet Glob Health. 2022 Jan;10(1):e87-e95. doi: 10.1016/S2214-109X(21)00409-5. PMID: 34919861.
Copy Download .nbib Format: NLM
Showing 265 to 271 of 271 entries